Tagged: Alpharadinn

Bayer and Oslo-based Algeta enter global agreement

Bayer Schering Pharma, Germany, has entered into a global agreement with Algeta ASA, Oslo, Norway, for the development of the cancer drug Alpharadin. Alpharadin is currently being evaluated in a global phase III trial...